Bitome is a two-year-old, Boston-based connected med device company. Its first product is a noninvasive tool for monitoring hydration status with broad applications across the dialysis, diabetic, sports performance, and maternal / fetal monitoring spaces. In a first application, Bitome's technology will precisely assess volume status in congestive heart failure (CHF) patients – a key, but hard to measure, biometric correlated with patient outcomes. In short, Bitome wants to use hydration monitoring technology to do for CHF, what glucose monitoring has done for diabetes.
BITOME NEWSVIEW ALL
YOU MIGHT ALSO BE INTERESTED IN